Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,294.9
0.0 (0.00%)

 

  • STI Straits Times Index
    3,294.9
    0.0 (0.00%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.1
    -0.7 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,965.5
    13.2 (0.05%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,522.6
    -32.5 (-0.91%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 805.0M
  • Value: 1,097.8M
  • Rise: 135
  • Fall: 158
  • Unch: 474

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.086+0.003
DISA0.009+0.001
ThaiBev0.660+0.005
The Place Hldg0.074+0.016
Geo Energy Res0.355+0.025
Sembcorp Marine0.083-
Arion Ent0.011+0.001
Singtel2.480+0.010
Oceanus0.029+0.001
Genting Sing0.775-0.005

World Indices

World Indices
Name Last Change
Nasdaq 13,768.9 -385.1
HSI 24,965.5 +13.2
HSCEI 8,787.3 +25.7
Jakarta 6,726.4 +99.5
Nikkei 225 27,522.3 -250.7
SSE Comp 3,522.6 -32.5
Shanghai A 3,691.5 -34.1
Shanghai B 286.2 -0.8
KOSPI 2,834.3 -28.4

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SILENCE THERAPEUTICS PLC SPON ADS EACH REP 3 ORD SHS SILENCE THERAPEUTICS PLC SPONSORED ADR
Updated on 21 Jan 2022 (End of trading day)
Last (USD): 19.950 Change: +1.240 High: 20.980 Remarks: -
Change (%): +6.63 Low: 18.200
Open 18.710 Yesterday's Close 18.71
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 20,041 Cumulative Value

Company Background

Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.39456 Trailing EPS (USD) b -1.86909 NAV (USD) c 1.0924
PE a - Trailing PE d - Price / NAV c 18.2625
Dividend Yield (%) e - Cash In Hand (USD) f 3.2883 Issued & Paid-up Shares g 29,928,200
Piotroski F Score 2 Market Cap (M) 597.068 Free Float (%) -
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 687.017
Net Earnings Growth (%) j -98.337 Net Debt/Equity k Net Cash
Sector & Industry Commercial Services - Miscellaneous Commercial Services
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 02 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.680
-7.77 %
10 Days --3.450
-14.74 %
20 Days --3.450
-14.74 %
Medium Term Return 3 Months --3.050
-13.26 %
6 Months --5.070
-20.26 %
1 Year --4.240
-17.53 %
Annualised Return Annualised --
-17.53 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SILENCE THERAPEUTICS PLC SPON ADS EACH REP 3 ORD SHS NASDAQ 597.068 - - 18.2625 -
Industry Miscellaneous Commercial Services NASDAQ 1,361.017 314.689 115.407 4.3461 0.184
Local Peer COPART INC NASDAQ 30,049.348 32.087 30.153 7.9206 -
Local Peer SYNEOS HEALTH INC NASDAQ 8,942.398 46.385 35.661 2.6934 -
Local Peer CONCENTRIX CORPORATION NASDAQ 8,762.725 21.606 21.606 3.3442 0.148
Local Peer THOUGHTWORKS HLDG INC NASDAQ 6,563.067 89.767 89.767 9.8054 -
Local Peer MARAVAI LIFESCIENCES HLDGS INC NASDAQ 6,303.318 81.981 42.036 20.8277 -
Local Peer R1 RCM INC NASDAQ 5,992.988 126.431 - 17.9380 -
Local Peer MEDPACE HOLDINGS INC NASDAQ 5,922.061 40.863 32.529 6.5941 -
Local Peer CDK GLOBAL INC NASDAQ 5,056.455 75.923 4.824 11.3018 1.442
Local Peer TRUPANION INC NASDAQ 3,751.004 - - 11.2992 -
Local Peer GRAND CANYON EDUCATION NASDAQ 3,357.767 13.055 12.817 2.3971 -
Local Peer PROGYNY INC NASDAQ 3,335.069 71.786 37.155 14.8812 -
Local Peer LAUREATE EDUCATION INC NASDAQ 2,898.764 - - 2.3352 -
Other Local Peers LEGALZOOM COM INC (NASDAQ), TASKUS INC (NASDAQ), FIRST ADVANTAGE CORP NEW (NASDAQ), ADAPTIVE BIOTECHNOLOGIES CORP (NASDAQ), EXSCIENTIA PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), REMITLY GLOBAL INC (NASDAQ), PRA GROUP INC (NASDAQ), STAGWELL INC (NASDAQ), ICF INTERNATIONAL INC (NASDAQ), FRANCHISE GROUP INC (NASDAQ), PAYONEER GLOBAL INC (NASDAQ), VERVE THERAPEUTICS INC (NASDAQ), REPAY HOLDINGS CORPORATION (NASDAQ), HEALTHCARE SERVICES GROUP INC (NASDAQ), EVO PAYMENTS INC (NASDAQ), CONDUENT INC (NASDAQ), FORRESTER RESEARCH INC (NASDAQ), HURON CONSULTING GROUP INC (NASDAQ), PAE INCORPORATED (NASDAQ), TELOS CORPORATION (NASDAQ), MONEYGRAM INTERNATIONAL INC (NASDAQ), WINMARK CORPORATION (NASDAQ), PAYA HOLDINGS INC (NASDAQ), PMV PHARMACEUTICALS INC (NASDAQ), CENTURY THERAPEUTICS INC (NASDAQ), ADAGIO THERAPEUTICS INC (NASDAQ), SP PLUS CORP (NASDAQ), CRA INTERNATIONAL INC (NASDAQ), NEWTEK BUSINESS SERVICES CORP COM USD0.02 (NASDAQ), ABSCI CORP (NASDAQ), ALX ONCOLOGY HLDGS INC (NASDAQ), DESIGN THERAPEUTICS INC (NASDAQ), PHARMING GROUP NV SPON ADS EACH REP 10 ORD SHS (NASDAQ), HACKETT GROUP INC (NASDAQ), CELULARITY INC (NASDAQ), ZYMERGEN INC (NASDAQ), TYRA BIOSCIENCES INC (NASDAQ), VIGIL NEUROSCIENCE INC (NASDAQ), WILLDAN GROUP INC (NASDAQ), VITRU LTD (NASDAQ), BIT DIGITAL INC (NASDAQ), ATOMERA INCORPORATED (NASDAQ), IMMUNEERING CORP (NASDAQ), INFORMATION SERVICES GROUP INC (NASDAQ), RALLYBIO CORP (NASDAQ), COMSCORE INC (NASDAQ), POINTS COM INC (NASDAQ), ACACIA RESEARCH CORP (NASDAQ), CODEX DNA INC (NASDAQ), CYTEIR THERAPEUTICS INC (NASDAQ), REKOR SYSTEMS INC (NASDAQ), LINCOLN EDUCATIONAL SERVICES CORP (NASDAQ), CANDEL THERAPEUTICS INC (NASDAQ), CELCUITY INC (NASDAQ), GAIA INC NEW (NASDAQ), PERFORMANT FINANCIAL (NASDAQ), LIXIANG EDUCATION HLDG SPON ADS EACH REP 5 ORD SHS REG S (NASDAQ), AUGMEDIX INC (NASDAQ), PAYSIGN INC (NASDAQ), CENTOGENE NV (NASDAQ), URBAN GRO INC (NASDAQ), WHERE FOOD COMES FROM (NASDAQ), TSCAN THERAPEUTICS INC (NASDAQ), ODYSSEY MARINE EXPLORATION (NASDAQ), ALJ REGIONAL HOLDINGS INC (NASDAQ), USIO INC (NASDAQ), LONGBOARD PHARMACEUTICALS INC (NASDAQ), CALYXT INC (NASDAQ), ALLIED ESPORTS ENTERTAINMENT INC (NASDAQ), METEN HOLDING GROUP LTD (NASDAQ), RESEARCH SOLUTIONS INC (NASDAQ), VIVOS THERAPEUTICS INC (NASDAQ), ATA CREATIVITY GLOBAL SPON ADS EACH REP 2 ORD SHS (NASDAQ), LM FUNDING AMERICA INC (NASDAQ), ZHONGCHAO INC (NASDAQ), LIGHTBRIDGE CORPORATION (NASDAQ), WORKSPORT LTD (NASDAQ), OPGEN INC (NASDAQ), CROWN ELECTROKINETICS CORP (NASDAQ), ELITE EDUCATION GRP INTL LTD (NASDAQ), RISE EDUCATION CAYMAN LTD SPON ADR EACH REP 2 ORD SHS (NASDAQ), DATASEA INC (NASDAQ), NEUROSENSE THERAPEUTICS LTD (NASDAQ), UNICYCIVE THERAPEUTICS INC (NASDAQ), SPAR GROUP INC (NASDAQ), WILHELMINA INTERNATIONAL INC (NASDAQ), SALARIUS PHARMACEUTICALS INC (NASDAQ),